146 related articles for article (PubMed ID: 490545)
1. Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
Murdock KC; Child RG; Fabio PF; Angier RB; Wallace RE; Durr FE; Citarella RV
J Med Chem; 1979 Sep; 22(9):1024-30. PubMed ID: 490545
[TBL] [Abstract][Full Text] [Related]
2. Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.
Wallace RE; Murdock KC; Angier RB; Durr FE
Cancer Res; 1979 May; 39(5):1570-4. PubMed ID: 427798
[TBL] [Abstract][Full Text] [Related]
3. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones as potential antileukemic agents.
Stefanska B; Dzieduszycka M; Martelli S; Borowski E
J Med Chem; 1989 Aug; 32(8):1724-8. PubMed ID: 2754697
[TBL] [Abstract][Full Text] [Related]
5. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones.
Zee-Cheng RK; Cheng CC
J Med Chem; 1978 Mar; 21(3):291-4. PubMed ID: 628005
[TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. 2. Bisguanylhydrazones of anthracene-9,10-dicarboxaldehydes.
Murdock KC; Child RG; Lin Y; Warren JD; Fabio PF; Lee VJ; Izzo PT; Lang SA; Angier RB; Citarella RV; Wallace RE; Durr FE
J Med Chem; 1982 May; 25(5):505-18. PubMed ID: 6806475
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antineoplastic evaluations of 5,8-bis[(aminoalkyl)amino]-1-azaanthracene-9,10-diones.
Krapcho AP; Landi JJ; Hacker MP; McCormack JJ
J Med Chem; 1985 Aug; 28(8):1124-6. PubMed ID: 4020835
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, peroxidating ability, and antineoplastic evaluation of 1-[(aminoalkyl)amino]-4-hydroxy-10-imino-9-anthracenones.
Dzieduszycka M; Martelli S; Tarasiuk J; Paradziej-Lukowicz J; Borowski E
J Med Chem; 1991 Feb; 34(2):541-6. PubMed ID: 1995874
[TBL] [Abstract][Full Text] [Related]
10. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
Leopold WR; Nelson JM; Plowman J; Jackson RC
Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
[TBL] [Abstract][Full Text] [Related]
11. 1,4-disubstituted anthracene antitumor agents.
Iyengar BS; Dorr RT; Alberts DS; Sólyom AM; Krutzsch M; Remers WA
J Med Chem; 1997 Nov; 40(23):3734-8. PubMed ID: 9371238
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems.
Krapcho AP; Landi JJ; Shaw KJ; Phinney DG; Hacker MP; McCormack JJ
J Med Chem; 1986 Aug; 29(8):1370-3. PubMed ID: 3735305
[TBL] [Abstract][Full Text] [Related]
13. Potential CNS antitumor agents--phenothiazines I: Nitrogen mustard derivatives.
Hirata T; Driscoll JS
J Pharm Sci; 1976 Nov; 65(11):1699-701. PubMed ID: 994007
[TBL] [Abstract][Full Text] [Related]
14. Vinylogous carbinolamine tumor inhibitors. 8. Activity of bis(acyloxymethyl) derivatives of pyrroles and pyrrolizines against a panel of murine leukemias and solid tumors.
Anderson WK; Chang CP; Corey PF; Halat MJ; Jones AN; McPherson HL; New JS; Rich AC
Cancer Treat Rep; 1982 Jan; 66(1):91-7. PubMed ID: 7053273
[TBL] [Abstract][Full Text] [Related]
15. Potential CNS antitumor agents VI: aziridinylbenzoquinones III.
Driscoll JS; Dudeck L; Congleton G; Geran RI
J Pharm Sci; 1979 Feb; 68(2):185-8. PubMed ID: 423089
[TBL] [Abstract][Full Text] [Related]
16. Active antitumor components in a decomposed amino sugar I: Effect of sugar structure on activity.
Khan AH; Driscoll JS
J Pharm Sci; 1975 Feb; 64(2):295-9. PubMed ID: 1127586
[TBL] [Abstract][Full Text] [Related]
17. Structural modification study of bis(substituted aminoalkylamino)anthraquinones. An evaluation of the relationship of the [2-[(2-hydroxyethyl)amino]ethyl]amino side chain with antineoplastic activity.
Zee-Cheng RK; Podrebarac EG; Menon CS; Cheng CC
J Med Chem; 1979 May; 22(5):501-5. PubMed ID: 458801
[TBL] [Abstract][Full Text] [Related]
18. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
Israel M; Modest EJ; Frei E
Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
[TBL] [Abstract][Full Text] [Related]
19. [Mitoxantrone HCl (1,4-dihydroxy-4, 8-bis[[2-(hydroxyethyl)-amino-ethyl)]amino 9,10-anthracenedione dihydrochloride (NSC 301739) - a new cytostatic].
Hagenberg L; Loynds P; Nagel GA
Onkologie; 1980 Dec; 3(6):322-8. PubMed ID: 6784060
[No Abstract] [Full Text] [Related]
20. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
